Overview
Gabriel Ramos practices practicing medicine in Jaboticabal, Brazil.
His clinical expertise encompasses Toxic Synovitis, Metabolic Acidosis, and Sudden Infant Death Syndrome (SIDS).
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Gabriel V. Ramos
Is Gabriel V. Ramos a top-rated expert for Toxic Synovitis?
MediFind is an objective health platform that identifies experts based on real-world data. Gabriel V. Ramos is classified as an Experienced expert for Toxic Synovitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Gabriel V. Ramos participate in research or clinical trials?
Yes. Gabriel V. Ramos has published 8 articles and abstracts on conditions like Toxic Synovitis. You can view a list of Gabriel V. Ramos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Metabolic AcidosisMr. Ramos isExperienced. Learn about Metabolic Acidosis.
- Sudden Infant Death Syndrome (SIDS)Mr. Ramos isExperienced. Learn about Sudden Infant Death Syndrome (SIDS).
- Toxic SynovitisMr. Ramos isExperienced. Learn about Toxic Synovitis.